Employing technology and tools licensed from Arizona Technology Enterprises (AzTE), bioSyntagma is working on extracting single and multi-cells from a variety of sample types using a simple, and cost effective, microfluidic tissue chip, the LightStream FloCellâ¢. The bioSyntagma solution allows cells to be analyzed using advanced technology such as next generation sequencing, and link the resulting information to the spatial location of the sample within the original tissue. This technology is indispensable for advancing scientific knowledge and the successful clinical treatment of cancer, diabetes, neurological disorders, and auto-immune diseases. The LightStream FloCell⢠is a simple, easy to use device that will address workflow issues that prevent the widespread adoption of complex NGS technologies. bioSyntagma's LightStream FloCell⢠allows researchers to identify single cells or regions of interest in FFPE or fresh frozen tissue, extract the area of interest, and transfer its contents to a downstream collection device. The location of the target is preserved and linked to the collected cellular contents, so any downstream analysis by methods such as qPCR or RNAseq can be correlated with the original tissue morpho
